US Patent Issued to Oyster Point Pharma on March 17 for "Use of varenicline for treating ocular conditions" (Nevada, Massachusetts, Texas Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,080, issued on March 17, was assigned to Oyster Point Pharma Inc..

"Use of varenicline for treating ocular conditions" was invented by Douglas Michael Ackermann Jr. (Reno, Nev.), James Loudin (Houston) and Kenneth J. Mandell (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods and pharmaceutical formulations for treating dry eye disease."

The patent was filed on April 3, 2025, under Application No. 19/169,843.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&...